Psoriasis & Rheumatoid Arthritis

According to a recent report by MarketsandMarkets, a market research firm, sales of drugs to treat autoimmune disease reached more than US$30 billion in 2007. These sales are forecasted to grow to a total global value of over US$50 billion in 2013.

According to the market research firm Global Industry Analysts (GIA), psoriasis affects 123 million people worldwide. The psoriasis drug market generated US$3.7 billion of revenue in 2009 and is expected to grow at a compounded annual growth rate of 12% and reach US$7.3 billion in revenue by 2015.

The worldwide market for Rheumatoid Arthritis, according to GIA, was more than US$14 billion in 2009 and is expected to grow to at a compounded rate of 8% and reach US$23 billion in 2015. XBiotech has not yet conducted a clinical trial for Rheumatoid Arthritis, but plans to do so within the next 12 months.